GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMF) » Definitions » Net Income Including Noncontrolling Interests

TRUMF (Terumo) Net Income Including Noncontrolling Interests : $773 Mil (TTM As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Terumo Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Terumo's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was $123 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was $773 Mil.

Terumo Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Terumo's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Net Income Including Noncontrolling Interests Chart

Terumo Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 710.23 748.99 668.28 710.02 784.78

Terumo Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 176.73 214.69 205.05 230.27 123.15

Terumo Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $773 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Terumo's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Terumo Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMF) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
TSE:7741 TSE:7747 TSE:3046 TSE:8086 TSE:3360 TSE:7716 TSE:7817 TSE:7730 TSE:3593 TSE:7780 ISRG XPAR:EL BDX XSWX:ALC RMD OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX
Traded in Other Exchanges
TRUMY:USA 4543:Japan TUO:Germany
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Website
https://www.terumo.com
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.